🕵️ Celcuity Inc. ($CELC)
SEC insider & ownership activity, last 12 months · CIK 1603454 · every row links its SEC filing
Over the last 12 months insiders sold $332.4M against $9.6M of open-market buying. Baker BROS. Advisors LP sold $317.8M in discretionary trades (Sep–Jul). No red-flag 8-Ks in the window.
🚨 1 signal active —
planned-vs-executed verdicts, pre-event flags, and cluster context live in the
API and the
alerts bot.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
1 buyer, $9.6M (4 lots) · 3 sellers, $332.4M (24 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Baker BROS. Advisors LP | 4 | $9.6M | 2 | $317.8M | Jul 14, 2026 |
| Dalvey David | 0 | – | 10 | $12.2M | May 4, 2026 |
| Richard E. Buller | 0 | – | 12 | $2.4M | May 4, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Baker BROS. Advisors LP | 10.0% | 13G | Jul 16, 2026 | filing ↗ | |
| Baker BROS. Advisors (GP) LLC | 10.0% | 13G | Jul 16, 2026 | filing ↗ | |
| Julian C. Baker | 10.0% | 13G | Jul 16, 2026 | filing ↗ | |
| Felix J. Baker | 10.0% | 13G | Jul 16, 2026 | filing ↗ | |
| Baker BROS. Advisors LP | 10.0% | 13D | Jul 14, 2026 | filing ↗ | |
| Baker BROS. Advisors (GP) LLC | 10.0% | 13D | Jul 14, 2026 | filing ↗ | |
| Julian C. Baker | 10.0% | 13D | Jul 14, 2026 | filing ↗ | |
| Felix J. Baker | 10.0% | 13D | Jul 14, 2026 | filing ↗ | |
| Soleus GP LLC | 9.9% | 13G | Feb 11, 2025 | filing ↗ | |
| Brian F. Sullivan | 9.1% | 13G | Nov 13, 2025 | filing ↗ | |
| Perceptive Advisors LLC | 6.8% | 13G | Feb 17, 2026 | filing ↗ | |
| Joseph Edelman | 6.8% | 13G | Feb 17, 2026 | filing ↗ | |
| Perceptive Life Sciences Master Fund, Ltd. | 6.8% | 13G | Feb 17, 2026 | filing ↗ | |
| Avoro Capital Advisors LLC | 6.7% | 13G | Feb 17, 2026 | filing ↗ | |
| Behzad Aghazadeh | 6.7% | 13G | Feb 17, 2026 | filing ↗ | |
| RTW Investments, LP | 6.3% | 13G | May 15, 2026 | filing ↗ | |
| Roderick Wong | 6.3% | 13G | May 15, 2026 | filing ↗ | |
| Blackrock, Inc. | 5.9% | 13G | Feb 4, 2025 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| 667, L.P. | $26.8M | Jul 14, 2026 | filing ↗ |
| Baker Brothers Life Sciences, L.P. | $291.0M | Jul 14, 2026 | filing ↗ |
| Richard E. Buller | $843K | May 4, 2026 | filing ↗ |
| Dalvey David | $3.5M | May 4, 2026 | filing ↗ |
| Richard E. Buller | $662K | Mar 31, 2026 | filing ↗ |
| Dalvey David | $2.4M | Jan 27, 2026 | filing ↗ |
| Richard E. Buller | $317K | Dec 5, 2025 | filing ↗ |
| Richard E. Buller | $108K | Dec 1, 2025 | filing ↗ |
| Dalvey David | $1.5M | Nov 21, 2025 | filing ↗ |
| Richard E. Buller | $377K | Nov 20, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Reg FD disclosure (7.01) | Jul 14, 2026 | filing ↗ |
| Other events (8.01) | Jul 14, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 14, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jul 14, 2026 | filing ↗ |
| Other events (8.01) | Jul 14, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 14, 2026 | filing ↗ |
| Material agreement (1.01) | Jun 3, 2026 | filing ↗ |
| Agreement terminated (1.02) | Jun 3, 2026 | filing ↗ |
| New financial obligation (2.03) | Jun 3, 2026 | filing ↗ |
| Other events (8.01) | Jun 3, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 3, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jun 2, 2026 | filing ↗ |
| Other events (8.01) | Jun 2, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 2, 2026 | filing ↗ |
| Officer/director changes (5.02) | May 18, 2026 | filing ↗ |
| Shareholder vote (5.07) | May 18, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 18, 2026 | filing ↗ |
| Earnings (2.02) | May 14, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 14, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | May 1, 2026 | filing ↗ |
| Other events (8.01) | May 1, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 1, 2026 | filing ↗ |
| Earnings (2.02) | Mar 25, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 25, 2026 | filing ↗ |
| Officer/director changes (5.02) | Feb 11, 2026 | filing ↗ |
| Officer/director changes (5.02) | Feb 11, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Feb 11, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 11, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Nov 17, 2025 | filing ↗ |
| Other events (8.01) | Nov 17, 2025 | filing ↗ |